Ascenta Therapeutics, Inc.

Small-molecule oncology therapeutics focusing on compounds that induce apoptosis (cell death) in tumor cells
(Formerly AccuTherapeutics, Inc)

(2004)

Location:
Malvern, PA

Management:
Mel Sorensen, CEO

UM Inventor(s):
Shaomeng Wang

Funding parties:
Domain Associates, Enterprise Partners, Pac-Link, Perseus LLC, Sofinnova Ventures, Scale Venture Partners, US Venture Partners